Uncategorized

Bristol Myers reaches a crossroads as a make-or-break year takes shape

Published

on

Bristol Myers Squibb is facing a bit of an identity crisis.

CEO Chris Boerner is nearly two and a half years into his tenure, with most of his time defined by

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version